Intervening to preserve function in ischemic cardiomyopathy with a porous hydrogel and extracellular matrix composite in a rat myocardial infarction model
Preprint
Abstract
A variety of hydrogels have been developed for intramyocardial injection therapy after myocardial infarction. Some of these biomaterials have incorporated bioactive substances that promote local tissue regeneration and integration, while others have emphasized the mechanical role of the injectate in providing functional benefit. In this study, we incorporated two bioactive features, porosity, and extracellular matrix derived hydrogel (ECM), into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N-isopropylacrylamide-co-N-vinylpyrrolidone-co-MAPLA) copolymer) and evaluated whether injection of this biomaterial could abrogate the remodeling process in a rat ischemic cardiomyopathy model. After myocardial infarction by coronary artery ligation, rats were randomly divided into four groups: group NP (non-porous hydrogel) without either ECM or porosity, group PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and group PME with porosity and ECM digest added to the synthetic copolymer. A group with PBS injection alone served as a control. Intramyocardial injections were made 3 days after myocardial infarction. Serial echocardiography was assessed over time, and histological assessments were performed eight weeks after infarction. Results demonstrated improved echocardiographic function and neovascularization in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated significant improvement in LV geometry and macrophage polarization (towards M2) compared to the PBS group, whereas these differences were not observed in the NP or PM groups versus the control. These results demonstrate that further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing a combination of mechanical and biological effects.Keywords
All Related Versions
- Published version: Advanced Healthcare Materials, 14 (2), e2402757.
This publication has 49 references indexed in Scilit:
- Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial InfarctionAdvanced Science, 2023
- Intra-myocardial alginate hydrogel injection acts as a left ventricular mid-wall constraint in swineActa Biomaterialia, 2020
- A New Era of Cardiac Cell Therapy: Opportunities and ChallengesAdvanced Healthcare Materials, 2018
- Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applicationsActa Biomaterialia, 2018
- Effects of hydrogel injection on borderzone contractility post-myocardial infarctionBiomechanics and Modeling in Mechanobiology, 2018
- One-Year Follow-Up Results from AUGMENT-HF: A Multicentre Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl in the Treatment of Heart FailureEuropean Journal of Heart Failure, 2015
- A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010JAMA Internal Medicine, 2015
- A Compressible Scaffold for Minimally Invasive Delivery of Large Intact Neuronal NetworksAdvanced Healthcare Materials, 2014
- Confinement and Deformation of Single Cells and Their Nuclei Inside Size‐Adapted MicrotubesAdvanced Healthcare Materials, 2014
- Porous Implants Modulate Healing and Induce Shifts in Local Macrophage Polarization in the Foreign Body ReactionAnnals of Biomedical Engineering, 2013